Published in BMJ Clin Evid on March 14, 2011
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Tech Coloproctol (2015) 0.92
High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol (2012) 0.81
Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg (2012) 3.63
A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology (2011) 3.03
Natural history of diverticular disease of the colon. Clin Gastroenterol (1975) 2.76
Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol (1975) 2.53
Symptomless diverticular disease and intake of dietary fibre. Lancet (1979) 2.45
The clinical significance of diverticulosis. Gastroenterology (1958) 2.26
Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study. Gut (2003) 2.05
Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology (2008) 2.01
Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br J Surg (1991) 1.74
Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum (1984) 1.70
Prospective study of physical activity and the risk of symptomatic diverticular disease in men. Gut (1995) 1.67
A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr (1994) 1.66
Medical and surgical therapy in diverticular disease: a comparative study. Gastroenterology (1976) 1.53
Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology (2011) 1.44
Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. Br Med J (Clin Res Ed) (1981) 1.44
Sigmoid diverticulitis: a systematic review. JAMA (2014) 1.38
How frequently do large bowel diverticula perforate? An incidence and cross-sectional study. Eur J Gastroenterol Hepatol (2000) 1.32
Epidemiology of perforated colonic diverticular disease. Postgrad Med J (2002) 1.32
Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg (2005) 1.30
Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut (2010) 1.28
A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann Epidemiol (1995) 1.14
The outcome in 455 patients admitted for treatment of diverticular disease of the colon. Br J Surg (1970) 1.13
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis (2002) 1.12
Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease. Br J Surg (2003) 1.10
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther (1995) 1.09
Diverticulitis. A comprehensive follow-up. Dis Colon Rectum (1996) 1.09
Complicated diverticular disease of the sigmoid colon. An analysis of short and long term outcome in 392 patients. Ann Chir Gynaecol (1979) 1.07
The placebo effect. Is it important in diverticular disease? Am J Gastroenterol (1977) 1.06
Current status of the treatment of acute colonic diverticulitis: a systematic review. Colorectal Dis (2012) 1.06
Treatment of perforated sigmoid diverticulitis: a prospective randomized trial. Br J Surg (1993) 1.04
Multicentre, randomized clinical trial of primary versus secondary sigmoid resection in generalized peritonitis complicating sigmoid diverticulitis. Br J Surg (2000) 1.02
Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci (2005) 1.02
Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol (2007) 1.02
A population-based study of perforated diverticular disease incidence and associated mortality. Gastroenterology (2008) 1.02
Smoking and the risk of diverticular disease in women. Br J Surg (2011) 1.00
Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol (2003) 0.99
Randomized controlled trial of oral vs intravenous therapy for the clinically diagnosed acute uncomplicated diverticulitis. Colorectal Dis (2008) 0.95
Long-term outcome of patients presenting with acute complications of diverticular disease. Ann R Coll Surg Engl (1994) 0.92
Randomized, prospective comparison of cefoxitin and gentamicin-clindamycin in the treatment of acute colonic diverticulitis. Clin Ther (1992) 0.91
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci (2007) 0.88
Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet. Br J Clin Pract (1990) 0.86
Evidence-based surgery: diverticulitis--a surgical disease? Langenbecks Arch Surg (2000) 0.85
Use of antibiotics in uncomplicated diverticulitis. Br J Surg (2011) 0.83
Functional bowel disorders. Gastroenterology (2006) 20.72
Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol (2006) 3.30
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology (2009) 1.97
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol (2003) 1.92
Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology (2011) 1.70
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut (2012) 1.30
In vivo imaging of intragastric gelation and its effect on satiety in humans. J Nutr (2004) 1.28
Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut (2010) 1.28
Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol (2006) 1.04
Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study. Clin Nutr (2009) 1.03
Information assimilation and distribution challenges and goals for real and virtual journals. J Clin Gastroenterol (2005) 1.02
A population-based study of perforated diverticular disease incidence and associated mortality. Gastroenterology (2008) 1.02
Improved methods for fMRI studies of combined taste and aroma stimuli. J Neurosci Methods (2006) 1.01
Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol (2003) 0.99
Diverticular abscess of the appendix: report of a case and review of the literature. Dis Colon Rectum (2003) 0.96
Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction. Am J Physiol Gastrointest Liver Physiol (2007) 0.94
Preventing gastric sieving by blending a solid/water meal enhances satiation in healthy humans. J Nutr (2012) 0.93
The effects of fasting and refeeding with a 'metabolic preconditioning' drink on substrate reserves and mononuclear cell mitochondrial function. Clin Nutr (2010) 0.92
Effect of intragastric acid stability of fat emulsions on gastric emptying, plasma lipid profile and postprandial satiety. Br J Nutr (2008) 0.89
Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. World J Gastroenterol (2008) 0.86
Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am J Gastroenterol (2002) 0.85
Age-related decline in rectal mucosal lymphocytes and mast cells. Eur J Gastroenterol Hepatol (2004) 0.85
The cortical response to the oral perception of fat emulsions and the effect of taster status. J Neurophysiol (2011) 0.85
Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy. Helicobacter (2003) 0.85
Estimating the importance of infection in IBS. Am J Gastroenterol (2003) 0.83
Magnetic resonance imaging of the behaviour of oil-in-water emulsions in the gastric lumen of man. Br J Nutr (2006) 0.79
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial. Trials (2013) 0.79
Gallbladder contraction, gastric emptying and antral motility: single visit assessment of upper GI function in untreated celiac disease using echo-planar MRI. J Magn Reson Imaging (2005) 0.79
Monitoring of gallbladder and gastric coordination by EPI. J Magn Reson Imaging (2005) 0.77
Colonic diverticular disease. Am Fam Physician (2011) 0.77
Mechanisms of postoperative intestinal motor dysfunction. Curr Opin Gastroenterol (2003) 0.77
Colonic diverticular disease. BMJ Clin Evid (2007) 0.77
Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm (2014) 0.76
Should we treat uncomplicated symptomatic diverticular disease with fibre? BMJ (2011) 0.75
Neuropathology of IBS? Gastroenterology (2002) 0.75
Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo. J Pharm Pharmacol (2002) 0.75
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis. Int J Pharm (2006) 0.75
Colonic diverticular disease: medical treatments for acute diverticulitis. BMJ Clin Evid (2016) 0.75
Diverticular disease: a fresh approach to a neglected disease. Preface. Dig Dis (2012) 0.75
IBD and IBS: novel mechanisms and future practice. Preface. Dig Dis (2010) 0.75